T1	AdverseReaction 30 51	RETINAL ABNORMALITIES
T2	AdverseReaction 66 77	VISION LOSS
T3	Factor 56 65	POTENTIAL
T4	AdverseReaction 90 111	RETINAL ABNORMALITIES
T5	AdverseReaction 126 137	VISION LOSS
T6	Factor 116 125	POTENTIAL
T7	AdverseReaction 160 181	retinal abnormalities
T8	AdverseReaction 160 181;208 218;233 260	retinal abnormalities similar to retinal pigment dystrophies
T9	AdverseReaction 291 319	damage to the photoreceptors
T10	AdverseReaction 324 335	vision loss
T12	AdverseReaction 493 516	decreased visual acuity
T13	Factor 440 465	not possible to determine
T14	AdverseReaction 723 755	retinal pigmentary abnormalities
T15	AdverseReaction 819 840	retinal abnormalities
T16	AdverseReaction 926 947	retinal abnormalities
T17	AdverseReaction 1901 1922	RETINAL ABNORMALITIES
T18	AdverseReaction 1937 1948	VISION LOSS
T19	Factor 1927 1936	POTENTIAL
T20	AdverseReaction 2042 2063	retinal abnormalities
T21	AdverseReaction 2042 2063;2090 2100;2123 2142	retinal abnormalities similar to pigment dystrophies
T22	AdverseReaction 2173 2201	damage to the photoreceptors
T23	AdverseReaction 2206 2217	vision loss
T11	AdverseReaction 2378 2401	decreased visual acuity
T24	Factor 2325 2350	not possible to determine
T25	Factor 150 153	can
T26	AdverseReaction 364 385	retinal abnormalities
T27	AdverseReaction 410 432	abnormal visual acuity
E1	AdverseReaction:T1
E2	AdverseReaction:T2 Hypothetical:E3
E3	Factor:T3
E4	AdverseReaction:T4
E5	AdverseReaction:T5 Hypothetical:E6
E6	Factor:T6
E7	AdverseReaction:T7 Hypothetical:E25
E8	AdverseReaction:T8 Hypothetical:E25
E9	AdverseReaction:T9
E10	AdverseReaction:T10
E12	AdverseReaction:T12 Negated:E13
E13	Factor:T13
E14	AdverseReaction:T14
E15	AdverseReaction:T15
E16	AdverseReaction:T16
E17	AdverseReaction:T17
E18	AdverseReaction:T18 Hypothetical:E19
E19	Factor:T19
E20	AdverseReaction:T20
E21	AdverseReaction:T21
E22	AdverseReaction:T22
E23	AdverseReaction:T23
E11	AdverseReaction:T11 Negated:E24
E24	Factor:T24
E25	Factor:T25
E26	AdverseReaction:T26
E27	AdverseReaction:T27
A1	CUI E1 C0035300
A2	UMLS-Preferred-Name E1 Abnormality of the retina
A3	MEDDRA-PT E1 Retinal disorder
A4	MEDDRA-PT-ID E1 10038853
A5	CUI E2 C3665386
A6	UMLS-Preferred-Name E2 Abnormal vision
A7	MEDDRA-PT E2 Blindness
A8	MEDDRA-PT-ID E2 10005169
A9	LLT E2 Vision loss
A10	LLT-ID E2 10047522
A11	CUI E4 C0035300
A12	UMLS-Preferred-Name E4 Abnormality of the retina
A13	MEDDRA-PT E4 Retinal disorder
A14	MEDDRA-PT-ID E4 10038853
A15	CUI E5 C3665386
A16	UMLS-Preferred-Name E5 Abnormal vision
A17	MEDDRA-PT E5 Blindness
A18	MEDDRA-PT-ID E5 10005169
A19	LLT E5 Vision loss
A20	LLT-ID E5 10047522
A21	CUI E7 C0035300
A22	UMLS-Preferred-Name E7 Abnormality of the retina
A23	MEDDRA-PT E7 Retinal disorder
A24	MEDDRA-PT-ID E7 10038853
A25	CUI E8 C0854723
A26	UMLS-Preferred-Name E8 Retinal Dystrophies
A27	MEDDRA-PT E8 Retinal dystrophy
A28	MEDDRA-PT-ID E8 10038857
A29	LLT E8 Pigmentary retinal dystrophy
A30	LLT-ID E8 10035017
A31	CUI E9 C0235272
A32	UMLS-Preferred-Name E9 Retinal damage
A33	MEDDRA-PT E9 Retinal injury
A34	MEDDRA-PT-ID E9 10057430
A35	LLT E9 Retinal damage
A36	LLT-ID E9 10038841
A37	CUI E10 C3665386
A38	UMLS-Preferred-Name E10 Abnormal vision
A39	MEDDRA-PT E10 Blindness
A40	MEDDRA-PT-ID E10 10005169
A41	LLT E10 Vision loss
A42	LLT-ID E10 10047522
A43	CUI E12 C0234632
A44	UMLS-Preferred-Name E12 Reduced visual acuity
A45	MEDDRA-PT E12 Visual acuity reduced
A46	MEDDRA-PT-ID E12 10047531
A47	LLT E12 Visual acuity decreased
A48	LLT-ID E12 10049061
A49	CUI E14 C0151891
A50	UMLS-Preferred-Name E14 Retinal depigmentation
A51	MEDDRA-PT E14 Retinal degeneration
A52	MEDDRA-PT-ID E14 10038845
A53	LLT E14 Retinal pigment degeneration
A54	LLT-ID E14 10038892
A55	CUI E15 C0035300
A56	UMLS-Preferred-Name E15 Abnormality of the retina
A57	MEDDRA-PT E15 Retinal disorder
A58	MEDDRA-PT-ID E15 10038853
A59	CUI E16 C0035300
A60	UMLS-Preferred-Name E16 Abnormality of the retina
A61	MEDDRA-PT E16 Retinal disorder
A62	MEDDRA-PT-ID E16 10038853
A63	CUI E17 C0035300
A64	UMLS-Preferred-Name E17 Abnormality of the retina
A65	MEDDRA-PT E17 Retinal disorder
A66	MEDDRA-PT-ID E17 10038853
A67	CUI E18 C3665386
A68	UMLS-Preferred-Name E18 Abnormal vision
A69	MEDDRA-PT E18 Blindness
A70	MEDDRA-PT-ID E18 10005169
A71	LLT E18 Vision loss
A72	LLT-ID E18 10047522
A73	CUI E20 C0035300
A74	UMLS-Preferred-Name E20 Abnormality of the retina
A75	MEDDRA-PT E20 Retinal disorder
A76	MEDDRA-PT-ID E20 10038853
A77	CUI E21 C0854723
A78	UMLS-Preferred-Name E21 Retinal Dystrophies
A79	MEDDRA-PT E21 Retinal dystrophy
A80	MEDDRA-PT-ID E21 10038857
A81	LLT E21 Pigmentary retinal dystrophy
A82	LLT-ID E21 10035017
A83	CUI E22 C0235272
A84	UMLS-Preferred-Name E22 Retinal damage
A85	MEDDRA-PT E22 Retinal injury
A86	MEDDRA-PT-ID E22 10057430
A87	LLT E22 Retinal damage
A88	LLT-ID E22 10038841
A89	CUI E23 C3665386
A90	UMLS-Preferred-Name E23 Abnormal vision
A91	MEDDRA-PT E23 Blindness
A92	MEDDRA-PT-ID E23 10005169
A93	LLT E23 Vision loss
A94	LLT-ID E23 10047522
A95	CUI E11 C0234632
A96	UMLS-Preferred-Name E11 Reduced visual acuity
A97	MEDDRA-PT E11 Visual acuity reduced
A98	MEDDRA-PT-ID E11 10047531
A99	LLT E11 Visual acuity decreased
A100	LLT-ID E11 10049061
A101	CUI E26 C0035300
A102	UMLS-Preferred-Name E26 Abnormality of the retina
A103	MEDDRA-PT E26 Retinal disorder
A104	MEDDRA-PT-ID E26 10038853
A105	CUI E27 C0234632
A106	UMLS-Preferred-Name E27 Reduced visual acuity
A107	MEDDRA-PT E27 Visual acuity reduced
A108	MEDDRA-PT-ID E27 10047531
